CD19 and neoplasm: First, we measured the in vitro cytotoxicity of the CAR19/IL-15 NK cells infused to patients against CD19-expressing tumor cells and showed that CAR-NK cells from Opt-Cs had greater long-term cytotoxicity against multiple tumor rechallenges, associated with greater metabolic fitness and polyfunctionality compared to Sub-Cs.